Neuropeptide Y, a potent orexigenic neuromodulator in the brain, increased BDNF mRNA and protein expression by inhibiting miR-30a-5p in an in vitro model of AD (Fig. 1) [173, 175]. The gene discussed is BDNF; the disease is Alzheimer disease.